Advanced Micro Devices/ US0079031078 /
2024-04-22 9:59:59 PM | Chg. +2.04 | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
148.58USD | +1.39% | 349,216 Turnover: 51.67 mill. |
-Bid Size: - | -Ask Size: - | 240.17 bill.USD | - | 280.45 |
GlobeNewswire
04-22
Cognition Therapeutics KOL Event Provided Platform for Valuable Discussion of Current Therapeutic Op...
GlobeNewswire
04-18
Ocular Therapeutix™ Announces Positive Topline Phase 1 Data for AXPAXLI™ in Diabetic Retinopathy
GlobeNewswire
04-16
AMD Expands Commercial AI PC Portfolio to Deliver Leadership Performance Across Professional Mobile ...
GlobeNewswire
04-16
Clearside Biomedical Appoints Seasoned Biotechnology Executive Anthony S. Gibney to its Board of Dir...
GlobeNewswire
04-16
Ocular Therapeutix™ Strengthens Clinical Team with Appointment of Key Retinal Leaders
GlobeNewswire
04-15
Ocular Therapeutix™ Executive Chairman Pravin U. Dugel, MD Becomes President and CEO Antony Mattessi...
GlobeNewswire
04-09
Ocular Therapeutix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) to Senior Vice Pre...
GlobeNewswire
04-09
AMD Extends Leadership Adaptive SoC Portfolio with New Versal Series Gen 2 Devices Delivering End-to...
GlobeNewswire
04-06
Ocular Therapeutix™ Announces Positive Phase 2 PAXTRAVA™ Glaucoma Data at the American Society of Ca...
GlobeNewswire
04-03
YieldMax™ ETFs Announces Monthly Distributions on MSTY (120.57%), CONY (119.30%), NVDY (106.86%), AM...